×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [7]
自动化研究所 [3]
内容类型
期刊论文 [10]
发表日期
2022 [10]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
限定条件
发表日期:2022
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors
期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:
Zhang,Pei
;
Du,Yang
;
Bai,Hua
;
Wang,Zhijie
;
Duan,Jianchun
收藏
  |  
浏览/下载:123/0
  |  
提交时间:2022/11/21
Tucidinostat
Tumor microenvironment
PD-L1
CCL5
Solid tumor
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
期刊论文
CANCERS, 2022, 卷号: 14
作者:
Xie, Mingying
;
Li, Na
;
Xu, Xiaoling
;
Xu, Yanjun
;
Li, Hui
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/22
liver metastasis
non-small cell lung cancer
PD-L1
PD-1
PD-L1 inhibitor
CD8+T cell
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:
He, Bing-Xi
;
Zhong, Yi-Fan
;
Zhu, Yong-Bei
;
Deng, Jia-Jun
;
Fang, Meng-Jie
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/06/10
Tumor biomarkers
immunotherapy
lung neoplasms
programmed cell death 1 receptor (PD-1 receptor)
biostatistics
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:
Li, Yue
;
Li, Chong
;
Jiang, Ya
;
Han, Xue
;
Liu, Sisi
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2022
作者:
Xu, Liwei
;
Qi, Yajun
;
Jiang, Youhua
;
Ji, Yongling
;
Zhao, Qiang
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/05
Gut microbiome
esophageal squamous cell carcinoma (ESCC)
neoadjuvant therapy
immunotherapy
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:
Song, Yuqin
;
Gao, Quanli
;
Zhang, Huilai
;
Fan, Lei
;
Zhou, Jianfeng
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/05/05
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Lin, Yuxin
;
Zhu, Wei
;
Wu, Bingchen
;
Lan, Huiyin
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/05/16
Sarcoid-like reaction
immune checkpoint inhibitor
Toripalimab
PD-1
case report
A Fast and Automated FMT/XCT Reconstruction Strategy Based on Standardized Imaging Space
期刊论文
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2022, 卷号: 41, 期号: 3, 页码: 657-666
作者:
An, Yu
;
Bian, Chang
;
Yan, Daxiang
;
Wang, Hanfan
;
Wang, Yu
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/06/06
Imaging
Image reconstruction
Mice
In vivo
Image segmentation
Finite element analysis
Surface reconstruction
Fluorescence molecular tomography
imaging reconstruction
standardized imaging space
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/02/14
Hodgkin lymphoma
PD-1 inhibitor
PD-L1 inhibitor
PD-L2
Molecular phenotype
Tumor microenvironment
©版权所有 ©2017 CSpace - Powered by
CSpace